Advanced search
Publication Cover
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration Volume 15, 2014 - Issue 3-4
Submit an article Journal homepage
1,453
Views
90
CrossRef citations to date
0
Altmetric
Research Article

Estimating clinical stage of amyotrophic lateral sclerosis from the ALS Functional Rating Scale

Rubika BalendraKing’s College London, Institute of Psychiatry, Department of Clinical Neuroscience
,
Ashley JonesKing’s College London, Institute of Psychiatry, Department of Clinical Neuroscience
,
Naheed JivrajHealth Service and Population Research, Institute of Psychiatry, King's College London
,
Catherine KnightsKing’s College London, Institute of Psychiatry, Department of Clinical Neuroscience
,
Catherine M. EllisDepartment of Neurology
,
Rachel BurmanDepartment of Palliative Care, King's College Hospital, London
,
Martin R. TurnerNuffield Department of Clinical Neurosciences, Oxford University, Oxford
,
P. Nigel LeighKing’s College London, Institute of Psychiatry, Department of Clinical Neuroscience;Brighton and Sussex Medical School, Trafford Centre for Biomedical Research, University of Sussex, Falmer, East Sussex, UK
,
Christopher E. ShawKing’s College London, Institute of Psychiatry, Department of Clinical Neuroscience
&
Ammar Al-ChalabiKing’s College London, Institute of Psychiatry, Department of Clinical NeuroscienceCorrespondence[email protected]
 show all
Pages 279-284 | Received 23 Sep 2013, Accepted 18 Feb 2014, Published online: 10 Apr 2014

References

  • Hardiman O, van den Berg LH, Kiernan MC. Clinical diagnosis and management of amyotrophic lateral sclerosis. Nature reviews Neurology. 2011;7:639–49.
  • Roche JC, Rojas-Garcia R, Scott KM, Scotton W, Ellis CE, Burman R, et al. A proposed staging system for amyotrophic lateral sclerosis. Brain : a journal of Neurology. 2012;135: 847–52.
  • Jones A, Jivraj N, Balendra R, Murphy C, Kelly M, Thornhill M, et al. Health utility decreases with increasing clinical stage in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2014. doi:10.3109/21678421.2013.872149.
  • Balendra R, Jones A, Jivraj N, Steen IN, Young CA, Shaw PJ, et al. Use of clinical staging in amyotrophic lateral sclerosis for phase III clinical trials. Journal of Neurology, Neurosurgery, and Psychiatry.2014 Jan 24. PubMed PMID: 24463480.
  • Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). Journal of the Neurological Sciences. 1999; 169:13–21.
  • Lanka V, Cudkowicz M. Therapy development for ALS: lessons learned and path forward. Amyotroph Lateral Scler.: official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.2008;9: 131–40.
  • Shrout PE, Fleiss JL. Intraclass Correlations - Uses in Assessing Rater Reliability. Psychol Bull. 1979;86:420–8.
  • McGraw KO, Wong SP. Forming inferences about some intraclass correlation coefficients. Psychol Methods. 1996;1:30–46.
  • Bland JM, Altman DG. Measurement error and correlation coefficients. Brit Med J. 1996;313:41–2.
  • Bland JM, Altman DG. Statistical Methods for Assessing Agreement between Two Methods of Clinical Measurement. Lancet. 1986;1:307–10.
  • Sedgwick P. Limits of agreement (Bland-Altman method). BMJ 2013;346:f1630.
  • Brooks BR, Miller RG, Swash M, Munsat TL, World Federation of Neurology Research Group on Motor Neuron D. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord.: official publication of the World Federation of Neurology,Research Group on Motor Neuron Diseases. 2000;1:293–9.
  • Young CA, Ellis C, Johnson J, Sathasivam S, Pih N. Treatment for sialorrhoea in people with motor neuron disease/amyotrophic lateral sclerosis. Cochrane Database Syst Rev. 2011 (5):CD006981. PubMed PMID: 21563158. Epub 2011/05/13. eng.
  • Costa J, Rocha ML, Ferreira J, Evangelista T, Coelho M, de Carvalho M. Botulinum toxin type-B improves sialorrhoea and quality of life in bulbar-onset amyotrophic lateral sclerosis. Journal of Neurology. 2008;255:545–50.
  • Newall AR, Orser R, Hunt M. The control of oral secretions in bulbar ALS/MND. Journal of The Neurological Sciences. 1996;139 (Suppl):43–4.
  • Franchignoni F, Mora G, Giordano A, Volanti P, Chio A. Evidence of multidimensionality in the ALSFRS-R scale: a critical appraisal on its measurement properties using Rasch analysis. Journal of Neurology, Neurosurgery, and Psychiatry. 2013 PubMed PMID: 23516308. Epub 2013/ 03/22. Eng.
  • Traynor BJ, Zhang H, Shefner JM, Schoenfeld D, Cudkowicz ME, Consortium N. Functional outcome measures as clinical trial endpoints in ALS. Neurology. 2004 23;63:1933–5.
  • Schoenfeld DA, Cudkowicz M. Design of phase II ALS clinical trials. Amyotroph Lateral Scler. 2008;9:16–23.
  • Meininger V. Clinical Trials in ALS: What Did We Learn from Recent Trials in Humans?Neurodegenerative Diseases. 2005;2:208–14.
  • Gordon PH, Cheng B, Salachas F, Pradat PF, Bruneteau G, Corcia P, et al. Progression in ALS is not linear but is curvilinear. Journal of Neurology. 2010;257:1713–7.
  • Gordon PH, Salachas F, Lacomblez L, Le Forestier N, Pradat PF, Bruneteau G, et al. Predicting Survival of Patients with Amyotrophic Lateral Sclerosis at Presentation: A 15-Year Experience. Neuro-degenerative diseases. 2012. PubMed PMID: 22922503. Epub 2012/08/28. Eng.
  • Talbot K. Motor neuron disease: the bare essentials. Practical Neurology. 2009;9:303–9.
  • Turner MR, Parton MJ, Shaw CE, Leigh PN, Al-Chalabi A. Prolonged survival in motor neuron disease: a descriptive study of the King’s database 1990–2002. Journal of Neurology, Neurosurgery, and Psychiatry. 2003;74:995–7.
  • Berry JD, Cudkowicz ME. New considerations in the design of clinical trials for amyotrophic lateral sclerosis. Clinical Investigation. 2011;1:1375–89.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.